Csenge Advisory Group Invests $1.03 Million in HCA Healthcare, Inc. $HCA

Csenge Advisory Group acquired a new position in HCA Healthcare, Inc. (NYSE:HCAFree Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 2,638 shares of the company’s stock, valued at approximately $1,028,000.

Several other large investors have also recently made changes to their positions in the company. BlackRock Inc. acquired a new position in HCA Healthcare during the second quarter worth approximately $5,069,974,000. State Street Corp grew its holdings in shares of HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after buying an additional 76,039 shares during the last quarter. Capital World Investors grew its stake in shares of HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after purchasing an additional 40,086 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after purchasing an additional 13,565 shares during the period. Finally, Norges Bank acquired a new position in HCA Healthcare in the 4th quarter valued at $1,262,513,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on HCA. Mizuho lowered their price objective on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a report on Tuesday, July 28th. JPMorgan Chase & Co. dropped their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 14th. TD Cowen reduced their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Finally, UBS Group lowered their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $465.59.

Check Out Our Latest Report on HCA Healthcare

HCA Healthcare Price Performance

NYSE:HCA opened at $407.28 on Thursday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The firm has a 50-day moving average of $395.75 and a two-hundred day moving average of $444.82. The stock has a market cap of $88.18 billion, a P/E ratio of 13.64, a PEG ratio of 1.43 and a beta of 1.10.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.84 earnings per share. As a group, equities analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Read More

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.